| Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function A Lother, S Berger, R Gilsbach, S Rösner, A Ecke, F Barreto, ... Hypertension 57 (4), 746-754, 2011 | 145 | 2011 |
| Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial A Supady, E Weber, M Rieder, A Lother, T Niklaus, T Zahn, F Frech, ... The Lancet Respiratory medicine 9 (7), 755-762, 2021 | 103 | 2021 |
| Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein A Greinacher, K Selleng, J Mayerle, R Palankar, J Wesche, S Reiche, ... Blood, The Journal of the American Society of Hematology 138 (14), 1269-1277, 2021 | 95 | 2021 |
| Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial A Bauer, M Schreinlechner, N Sappler, T Dolejsi, H Tilg, BA Aulinger, ... The Lancet Respiratory Medicine 9 (8), 863-872, 2021 | 79 | 2021 |
| Serum ACE2, angiotensin II, and aldosterone levels are unchanged in patients with COVID-19 M Rieder, L Wirth, L Pollmeier, M Jeserich, I Goller, N Baldus, B Schmid, ... American journal of hypertension 34 (3), 278-281, 2021 | 79 | 2021 |
| Adrenergic repression of the epigenetic reader MeCP2 facilitates cardiac adaptation in chronic heart failure SC Mayer, R Gilsbach, S Preissl, EB Monroy Ordonez, T Schnick, N Beetz, ... Circulation research 117 (7), 622-633, 2015 | 64 | 2015 |
| MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses I Volkmann, R Kumarswamy, N Pfaff, J Fiedler, S Dangwal, A Holzmann, ... Circulation research 113 (8), 997-1003, 2013 | 63 | 2013 |
| Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation A Decker, M Welzel, K Laubner, S Grundmann, G Kochs, M Panning, ... American Journal of Transplantation 20 (11), 3239-3245, 2020 | 61 | 2020 |
| Preserved recovery of cardiac function following ischemia–reperfusion in mice lacking SIRT3 C Koentges, K Pfeil, M Meyer-Steenbuck, A Lother, MM Hoffmann, ... Canadian journal of physiology and pharmacology 94 (1), 72-80, 2016 | 52 | 2016 |
| Mineralocorticoids in the heart and vasculature: new insights for old hormones A Lother, M Moser, C Bode, RD Feldman, L Hein Annual review of pharmacology and toxicology 55, 289-312, 2015 | 52 | 2015 |
| Cardiac endothelial cell transcriptome A Lother, S Bergemann, L Deng, M Moser, C Bode, L Hein Arteriosclerosis, Thrombosis, and Vascular Biology, 2018 | 49 | 2018 |
| Deoxycorticosterone Acetate/Salt–Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure A Lother, D Fürst, S Bergemann, R Gilsbach, F Grahammer, TB Huber, ... Hypertension 67 (1), 130-138, 2016 | 49 | 2016 |
| Sympathetic α2-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload R Gilsbach, J Schneider, A Lother, S Schickinger, J Leemhuis, L Hein Cardiovascular research 86 (3), 432-442, 2010 | 46 | 2010 |
| Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload N Beetz, C Rommel, T Schnick, E Neumann, A Lother, ... Journal of molecular and cellular cardiology 101, 145-155, 2016 | 43 | 2016 |
| Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis J Schneider, A Lother, L Hein, R Gilsbach Basic research in cardiology 106, 591-602, 2011 | 42 | 2011 |
| The transcription factor ETV1 induces atrial remodeling and arrhythmia C Rommel, S Roesner, A Lother, M Barg, M Schwaderer, R Gilsbach, ... Circulation Research 123 (5), 550-563, 2018 | 34 | 2018 |
| Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19 M Rieder, I Goller, M Jeserich, N Baldus, L Pollmeier, L Wirth, A Supady, ... Journal of Thrombosis and Thrombolysis 50, 558-566, 2020 | 33 | 2020 |
| Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity A Lother, S Bergemann, J Kowalski, M Huck, R Gilsbach, C Bode, L Hein Cardiovascular research 114 (2), 282-290, 2018 | 30 | 2018 |
| Anti-SARS-CoV-2 spike protein and anti-platelet factor 4 antibody responses induced by COVID-19 disease and ChAdOx1 nCov-19 vaccination A Greinacher, K Selleng, J Mayerle, R Palankar, J Wesche, S Reiche, ... | 27 | 2021 |
| Pharmacology of heart failure: From basic science to novel therapies A Lother, L Hein Pharmacology & therapeutics 166, 136-149, 2016 | 27 | 2016 |
Ralf GilsbachInstitute of Experimental Cardiology, University of HeidelbergBestätigte E-Mail-Adresse bei uni-heidelberg.de
